Procedures such as gastric bypass or sleeve gastrectomy have demonstrated substantial long-term weight loss and improvement in obesity-related conditions including type 2 diabetes, hypertension, and obstructive sleep apnoea
For manufacturers launching specialty products with high patient cost-sharing burdens, this dynamic can undermine the commercial value of an otherwise well-funded patient support program
Your provider wont simply write a prescription and have it fill without review
7.5 mg/46 mg (phentermine 7.5 mg and topiramate 46 mg) (equivalent to 9.33 mg of Phentermine Hydrochloride USP)
Global GLP-1 innovation is being driven by major pharmaceutical leaders including Novo Nordisk A/S, Eli Lilly and Company, Sanofi, Boehringer Ingelheim International GmbH, Amgen Inc., Biocon, and Teva Pharmaceuticals, who continue to expand treatment options across diabetes, obesity, and metabolic disorders